Consistently LCOR did not increase T cell killing of AT3-OVA-ER tumor cells, but LSKAA or LCOR with E2-depleted media did increase OT-I CD8+ T cell–mediated killing (Supplemental Figure 6E). Here, CD8A is linked to neoplasm.